Project Finder

Browse ongoing and completed research projects.

Since the founding of the BioMed X Institute in Heidelberg in 2013, we have completed numerous research projects, the majority of which have been transferred to our pharmaceutical partners for further development. In addition, our research has resulted in a substantial number of publications in peer-reviewed scientific journals.

Search our site

Common search terms

Project Finder

Advanced Biomarker Detection for Pharmacological Monitoring in the Brain

AI-Enabled Therapy of Early Diabetic Kidney Disease in Barbados

Circuit-Based Model Systems of Anhedonia

Complex Human Ex Vivo Models of Tissue Inflammation

Neural Circuit Regulation of Immune Function

New Strategies for Targeting of Solid Tumors with Multi-Specific Biologics

New Strategies to Engage Neutrophils in Solid Tumors

New Strategies to Enhance the Immunogenicity of Tumors

New Strategies to Target Autoreactive Plasma Cells

Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates

Brain Microcircuits in Psychiatric Diseases

DNA Damage in Cancer

Early Intervention in Psychiatric Diseases

Epigenetics and COPD

Extrachromosomal DNA in Cancer

Immunosuppressive Microenvironment of Tumors

Intestinal Epithelial Barrier in Autoimmune Diseases

Metabolism and Signaling in Cancer

Nanomaterial-Based Biosensors for Near-Patient Testing

Oral Biofilm Disruption

Pathogen-Mediated Modulation of Innate Immunity

Protective Tissue Factors in Autoimmune Diseases

Rapid Identification of Auto-Antigens in Autoimmune Diseases

RNA Splicing in Cancer

Selective Kinase Inhibitors

Tau-Mediated Neurodegeneration in Alzheimer’s Disease

Tracing Immune Cell Dysfunction in Autoimmunity and Neuroinflammation

Translocation of Complex Macromolecules Across the Intestinal Epithelial Barrier

AI Enabled Design and Optimization of Antibodies for Targeted Therapies

AI Powered Discovery to Enable Molecular Glue Therapies

AI-Powered Drug Discovery of New High-Affinity Small Molecules

AI/ML Platform for Targeting RNA With Small Molecules

De Novo Computational Design of Therapeutic Antibodies

New AI-Empowered Platform for Sterically Guided Design of Bispecific Antibodies

New Platform for Next-Generation Intraocular Biologics

New Strategies for Female-Controlled Non-Hormonal Contraception

Next-Generation Clinically Relevant Models of Fibrosis and Wound Healing

Prediction of Clinical Trial Outcome in Biomarker-Stratified Cancer Patient Populations